Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
Our findings support the use of repetitive DaT imaging for objectively monitoring PD progression. This could facilitate personalized disease tracking, subtyping, and intervention testing in the future. ANN NEUROL 2025;98:120-135.
Authors
- Gérard N. Bischof (ORCID: https://orcid.org/0000-0002-4366-5171)
- Verena Dzialas (ORCID: https://orcid.org/0000-0001-7226-6674)
- Kathrin Möllenhoff (ORCID: https://orcid.org/0000-0001-7861-3892)
- Thilo van Eimeren (ORCID: https://orcid.org/0000-0002-6951-2325)
- Alexander Drzezga (ORCID: https://orcid.org/0000-0001-6018-716X)
Institutions
- Forschungszentrum Jülich (DE)
- University of Cologne (DE)
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Annals of Neurology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1002/ana.27223
- Citations
- 14
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 19.45
Funders
- Deutsche Forschungsgemeinschaft